Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$15.11
-8.09%
Mkt Cap $469.55M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
Implied Upside
+118.4%
Consensus $33.00 vs current $15.11
NASDAQ·Healthcare·Biotechnology
$15.11
-8.09%
Mkt Cap $469.55M
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
+118.4%
Consensus $33.00 vs current $15.11